Gains:
- Ability to understand RNA-seq workflow, differential expression analysis and multiple testing correction (FDR) and have artificial intelligence produce verifiable analysis code
- Ability to critically interpret pathway enrichment results statistically and biologically
- Ability to exercise the discipline of checking statistical assumptions and multiple testing pitfalls and independently verifying biological significance.
“Omics” is the collective name for approaches that measure all molecules of a cell or tissue together: genomics (all DNA), transcriptomics (all RNA/expression), proteomics (all proteins), metabolomics (all metabolites). This data is huge — an RNA-seq experiment involves measurements of tens of thousands of genes. In this unit, you will learn how to use artificial intelligence (AI) as an assistant in omics analysis that writes code, selects statistics, and drafts biological interpretation; but you will learn why you must verify the statistical and biological result.
Critical warning: In Omics, the most dangerous errors are statistical and invisible. The AI can write code that bypasses multiple comparison correction (below), chooses the wrong test, or produces “false positive” gene lists. Additionally, AI can make up biological claims such as "this gene increases in that disease" without any source. The right way: to do the analysis with executable, auditable code and confirm each biological claim in the literature.
Basic concepts
- Expression: How much a gene is translated into RNA; measure of "activity".
- Differential expression (DE): Genes whose expression changes significantly between two groups (e.g., patient/healthy).
- p-value: The probability that a difference is a coincidence; if it is small, the difference is considered "significant".
- Multiple comparison correction: When tens of thousands of genes are looked at at the same time, by chance there will be some that are "significant". To fix this, methods such as FDR (false discovery rate) / Benjamini-Hochberg are used. If this correction is omitted, hundreds of false findings will arise.
- log2 fold change (log2FC): The logarithm of the expression ratio of a gene between two groups to the base 2; +1 means a twofold increase, −1 means a twofold decrease.
- Pathway enrichment: Finding in which biological pathways (e.g. cell division, immunity) the changed genes are concentrated; Databases such as GO and KEGG are used.
- Batch effect: Non-biological spurious difference arising from processing samples on different days/devices.
Step by step: AI-powered omics analysis
1. Clarify the experimental design and question. How many samples, how many groups, how many repetitions? Is statistical power sufficient? Explain the design to the AI.
2. Select the appropriate tool/method with AI. For RNA-seq, choose standard methods such as DESeq2/edgeR (statistical packages designed for count data); Use proven methods rather than a statistic that the AI “made up”.
3. Run the code and check the intermediate outputs. Do not proceed to DE analysis without normalization, batch effect control, quality plots (PCA).
4. Enforce multiple comparison correction. Filter results by corrected value (padj/FDR), not raw p-value.
5. Confirm the biological interpretation in the literature. Interpret pathway enrichment output with AI, but verify each claim at source.
Tip: In a DE analysis, look at the quality and aggregate impact graphs first. If samples are clustered by the day they were processed rather than by biological group, most of the "significant" genes you find are cumulative effects, not real biology.
three mini cases
Case 1 — Uncorrected p-value. A student tested 20,000 genes with the code written by the AI and found "540 significant genes." When he examined the code, he saw that the AI had skipped multiple comparison correction. When FDR correction was added, the number of significant genes decreased to 32. Without the correction, more than 500 false genes would be based on the story.
Case 2 — Fabricated biological claim. For a gene on the DE list, a researcher asked the AI "what does this gene do in this disease?" he asked; AI explained a convincing mechanism and the article. When he searched on PubMed, he saw that neither that mechanism nor the article existed. The claim was removed from the report.
Case 3 — Confirmation gained. A PhD student noticed that the samples were separated by two days in the PCA plot. Asked the AI to add a batch effect variable to the code; After the correction, the gene list was completely changed and became biologically significant. Without the quality control chart, a fake result could have been published.
Example: filtering with corrected p-value
import pandas as pd# let table 'de' be results from a DE tool (DESeq2/edgeR):# columns: gene, log2FC, pvalue, padj (FDR-corrected)de = pd.read_csv("de_results.csv")significant = de[(de["padj"] < 0.05) & (de["log2FC"].abs() >= 1)]print("Raw p<0.05:", (de["pvalue"] < 0.05).sum())print("FDR-corrected padj<0.05 & |log2FC|>=1:", len(significant))
The difference between the raw and corrected number illustrates why multiple comparisons are critical.
Four copyable templates
1) Analysis plan and method selection:
Your role: bioinformatics assistant. Set up analysis plan for the following RNA-seq experiment:[number of groups, number of samples/replicates, question]. Which standard tool (DESeq2/edgeR) should I choose and why, what quality control steps (PCA, batch effect) are required, how do I apply multiple comparison correction? Write step by step.
2) Code + mandatory checks:
Write executable code that performs the following DE analysis: [detail]. The code MUST include normalization, PCA quality plot, batch effect control, and FDR (Benjamini-Hochberg) correction. Comment each step. Filter with corrected p-value, not raw p-value.
3) Pathway enrichment comment:
Help interpret pathway enrichment results for this list of significant genes: [list/output]. Explain which pathways are prominent, but tell me in which source (GO, KEGG, peer-reviewed article) to confirm each biological claim. Mechanism/article FITTING.
4) Statistics audit:
Check the following analysis code for statistical errors: [code]. Specifically: incorrect test selection, omission of multiple comparison correction, ignoring batch effect, insufficient replication. List each problem you found and its fix.
Weak prompt / Strong prompt
Weak: "Find significant genes in this RNA-seq data."
Problem: Method, quality control, and multiple comparisons are not specified; AI can give a list full of false positives without correction.
Strong: "Write a code that performs DE analysis for this RNA-seq count data with DESeq2 logic, includes quality control and bulk effect control with PCA, and filters with FDR correction; comment each step and explain why you chose this method."
Why it is powerful: The method is standard, quality and correction are mandatory, the result is auditable.
Risk
symptom
precaution
false positive
Too many "meaningful" genes
FDR/multiple comparison correction
collective impact
Samples are clustered by day
PCA + batch variable
wrong test
Normal test to count data
Appropriate method like DESeq2/edgeR
made up biology
Weldless mechanism
Literature confirmation
insufficient power
1-2 reps
Enough repetition in design
Common mistakes
- Skipping multiple comparison correction. The most common and most harmful statistical error.
- Ignoring the collective impact. It produces false biological difference.
- Applying incorrect testing to count data. RNA-seq requires special methods.
- Accepting biological claims without source. AI can make up mechanisms and articles.
- Generalizing with insufficient repetition. Without statistical power, the result is unreliable.
Caution: “Statistically significant” is not the same as “biologically significant.” A very small but technically significant fold change may be biologically insignificant; In large samples everything can turn out to be "significant". Evaluate log2FC and p-value together.
Depth: background and double-counting pitfalls in pathway enrichment
Pathway enrichment results rely on two hidden assumptions that most people don't realize, and AI can silently bypass them. The first is background/universe selection: enrichment compares the set of "genes that changed" with the set of "which genes were looked at". If the background is taken from the entire genome but your experiment only measures a specific tissue panel, the results appear artificially “enriched.” Correct background are genes that can actually be expressed/measured in the experiment. One team found “highly significant enrichment of the immune pathway” by mistakenly backgrounding the entire genome; When the analysis was repeated with the correct background (measured genes), the enrichment disappeared—the finding was a method artifact.
Second, gene set size and double counting: very large and general pathways (e.g. “metabolic processes”, thousands of genes) appear “significant” in almost every list; small, specific pathways are more informative. Additionally, because the same gene is found in multiple pathways, it is misleading to treat overlapping pathways as independent evidence. Third point: it does not show the direction of enrichment; A pathway may be enriched, but half of the genes within it may be increased and the other half may be decreased. To see this, it is necessary to separately examine directional information (such as GSEA).
trap
symptom
precaution
wrong background
Everything seems enriched
Get measured genes background
Very general pathway
"Metabolism" always comes up
Focus on small, specific pathways
double counting
overlapping pathways
Don't take it as independent evidence
skip direction
mixed ascending/descending
Directional control with GSEA
In summary
- AI in omics analysis; is an assistant who selects methods, writes code, and drafts comments; statistics and biology decisions must be justified.
- Standard, proven methods (DESeq2/edgeR) should be used; Quality control and collective impact auditing should not be skipped.
- Multiple comparison correction (FDR) is mandatory; the results are filtered with the corrected value.
- Every biological claim must be confirmed in the literature; "significant" should be distinguished from "important".
Application task
Take a sample DE results table (or an open RNA-seq dataset). Compare significant gene counts based on raw p-value and corrected padj thresholds with the snippet above. Comment on the difference in one sentence. Then ask for biological interpretation with template 3 for a featured gene and check the claim yourself in PubMed.
checklist
- [ ] I evaluated the experimental design and statistical power.
- [ ] I chose a standard, convenient method.
- [ ] I did PCA and batch effect quality control.
- [ ] I applied multiple comparison (FDR) correction.
- [ ] I filtered the results with corrected p-value.
- [ ] I confirmed the biological claims in the literature.